Association of the HLA antigens with early atheromatosis in subjects with type 2 diabetes mellitus

International Angiology

Volumn 21, Issue 4, 2002, Pages 379-383

  Diamantopoulos, E J ^a   Andreadis, E A ^a   Kakou, M G ^a   Vassilopoulos, C V ^a   Vlachonikolis, I G ^b   Giannakopoulos, N A ^a   Tarassi, K E ^a   Papasteriades, C A ^a   Nicolaides, A N ^c,d  

^a EVANGELISMOS HOSPITAL   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Carotid artery; Diabetes mellitus; HLA A antigens; Tunica intima; Tunica media

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HLA A ANTIGEN; HLA A3 ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ARTERY DILATATION; ARTICLE; ATHEROMATOSIS; ATHEROSCLEROSIS; B LYMPHOCYTE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; COMMON CAROTID ARTERY; CONTROLLED STUDY; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; HUMAN; HYPERTENSION; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PHENOTYPE; T LYMPHOCYTE;

AGED; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; DIABETES MELLITUS, TYPE 2; FEMALE; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 0036941242     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population 16 year follow-up study. Diabetes 1973;23:105-11.
2. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 1979;59:8-13.
3. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979;241: 2035-8.
4. Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano K. Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 1987;257:949-52.
5. Baldassarre D, Werba JP, Tremoli E, Poli A, Pazzucconi F, Sirtori CR. Common carotid intima-media thickness measurement. A method to improve accuracy and precision. Stroke 1994;25:1588-92.
6. Bots ML, Mulder PG, Hofman A, van Es GS, Grobbee DE. Reproducibility of carotid vessel wall thickness measurements: the Rotterdam Study. J Clin Epidemiol 1994;47:921-30.
7. Heiss G, Sharett AR, Barness R, Chambless LE, Szklo M, Alzola C et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991;134:250-6.
8. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245-9.
9. Wagenknecht LE, D'Agostino R Jr, Savage PJ, O'Leary DH, Saad MF, Haffner SM. Duration of diabetes and carotid wall thickness: the Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997;28:999-1005.
10. Niskanen L, Rauramaa R, Miettinen H, Haffner SM, Mercuri M, Uusitupa M. Carotid artery intima-media thickness in elderly patients with NIDDM and in non-diabetic subjects. Stroke 1996;27:1986-92.
11. Yamasaki W, Kawamori R, Matsushima H, Nishizawa H, Kontama M, Kubota M et al. Asymptomatic hyperglycemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia 1995;38:585-91.
12. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
13. Brostoff J, Scadding; G, Male D, Roit I. Clinical immunology. New York, London: Gower Medical Publishing, 1992.
14. Diamantopoulos EJ, Andreadis EA, Vassilopoulos CV, Vlachonikolis IG, Tarassi KE, Chatzis NA et al. Association of specific HLA phenotypes with left ventricular mass and carotid intima-media thickness in hypertension. Am J Hypertens 2001;14:632-6.
15. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999;22:S5-18.
16. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000;23:S4-19.
17. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999;17:151-83.
18. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-32.
19. Terasaki PI, Beruoco D, Parks MS, Ozfurk Eroglu G. Microdroplet testing for HLA -A, B, C and -D antigens. Am J Clin Pathol 1978;69:103-20.
20. Vartdal F, Gandernack G, Funderud S, Bratlie A. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation-a fast and reliable technique. Tissue Antigens 1986;28:301-12.
21. Tao Z, Zhao Y, Zhu X, Zhu K, Yu G, Wu W et al. An association study between essential hypertension and HLA-DR1 alleles. Chin Med Sci J 1995;10:70-2.
22. Luque Otero M, Martell Claros N, Llorente Perez L, Fernadez Pinilla C, Martell Claros N. Severe hypertension in the Spanish population. Association with specific HLA antigens. Hypertension 1983;5:V149-52.
23. Crook MA, Tutt P, Simpson H, Pickup JC. Serum sialic acid and acute-phase proteins in type 1 and type 2 diabetes mellitus. Clin Chim Acta 1993;219:131-8.
24. Armalich F, Hermanz A, Lopez-Maderuelo D, Pena JM, Camacho J, Madero R et al. Enhanced acute-phase response and oxidative stress in older adults with type 2 diabetes. Horm Metab Res 2000;32:407-12.